ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis

Yang, Yuanming; Hua, Yiwei; Chen, Weihuan; Zheng, Huan; Wu, Haomeng; Qin, Shumin*; Huang, Shaogang*广东省人民医院; 广州中医药大学
Frontiers in Pharmacology2022-11-30DOI: 10.3389/fphar.2022.1037856
4被引8阅读
引用收藏
分享

摘要

Evidence of the advantages of Coptidis Rhizoma (CR) for the treatment of ulcerative colitis (UC) is accumulating. However, research revealing the targets and molecular mechanisms of CR against UC is scarce. In this research, a bioinformatics analysis was performed to carry out the physicochemical properties and biological activities of phytochemicals in CR and analyze the binding activities, targets, biological functions and mechanisms of CR against UC. This research shows that the CR's key phytochemicals, which are named Coptisine, Berberrubine, Berlambine, Berberine, Epiberberine, Obacunone, Worenine, Quercetin, (R)-Canadine, Magnograndiolide, Palmatine and Moupinamide, have ideal physicochemical properties and bioactivity. A total of 1,904 potential phytochemical targets and 17,995 UC-related targets are identified, and we finally acquire 233 intersection targets between key phytochemicals and disease. A protein-protein interaction network of 233 common targets was constructed; and six hub targets were acquired with a degree greater than or equal to median, namely TP53, HSP90AA1, STAT3, ESR1, MYC, and RELA. The enrichment analysis suggested that the core targets may exert an impact on anti-inflammatory, immunoregulatory, anti-oxidant and anti-fibrosis functions mainly through the PI3K/ART signaling pathway, Th17 differentiation signaling pathway, inflammatory bowel disease signaling pathway, etcetera. Also, a molecular docking analysis shows that the key phytochemicals have strong affinity for binding to the core targets. Finally, the interaction network of CR, phytochemicals, targets, GO functions, KEGG pathways and UC is constructed. This study indicates that the key phytochemicals in CR have superior drug likeness and bioactivity, and the molecular mechanism of key phytochemicals against UC may be via the signaling pathway mentioned above. The potential and critical pharmacological mechanisms provide a direction for future research.

学科与关键词

关键词
Coptidis RhizomaHuanglianulcerative colitissystem pharmacologybioinformatics analysis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-11-30
卷期
第 13 卷
页码
1037856
DOI
10.3389/fphar.2022.1037856
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81274318, U20A20397]; National Natural Science Foundation of Guangdong [2021A1515011498]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]; Guangdong Provincial key research and development program [2020B1111100010]; Guangzhou Science and Technology Planning Project [202201020288]; Special Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ13, SZ2021ZZ25, SZ2021ZZ44, SZ2021ZZ02]

作者

  • Y

    Yang, Yuanming (第一作者)

    guangzhou univ chinese med

  • H

    Hua, Yiwei

    2 · guangzhou univ chinese med

查看全部 7 位作者收起作者
  • C

    Chen, Weihuan

    2 · guangzhou univ chinese med

  • Z

    Zheng, Huan

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Haomeng

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Q

    Qin, Shumin (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    Huang, Shaogang (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417